Cartesian Therapeutics Inc — 貸借対照表 (NASDAQ:RNAC) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 165.44 M159.88 M165.89 M305.05 M435.02 M296.41 M 負債合計 183.44 M137.36 M72.06 M444.68 M441.82 M422.65 M 純資産合計 -18.01 M22.52 M93.83 M-440.18 M-6.8 M-126.24 M 負債および純資産合計 165.44 M159.88 M165.89 M305.05 M435.02 M296.41 M 有利子負債合計 24.79 M25.63 M26.26 M0—— 純負債 -128.13 M-92.77 M-96.68 M-65.96 M——

ニュース

Cartesian Therapeutics, Inc. (RNAC) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript

BTIGがCartesian Therapeutics株にBuy評価を継続、目標株価44ドル

BTIG reiterates Buy on Cartesian Therapeutics stock, $44 target

Mizuho、治験進展を受けてCartesian Therapeutics株の投資判断を維持

Mizuho reiterates Cartesian Therapeutics stock rating on trial progress

Kyverna Stock: The King Of The CAR-T Autoimmune Revolution (NASDAQ:KYTX)

Cartesian Therapeutics, Inc. (RNAC) Upgraded to Buy: What Does It Mean for the Stock?

Johnson & Johnson Touts Positive Results For Lupus Treatment - Johnson & Johnson (NYSE:JNJ)

2026 Market Outlook: Focus On Pharma For Consistent Returns, Potential Skyrocketing Shares

H.C.ワインライト、カーテシアン・セラピューティクスの株価目標を40ドルから30ドルに引き下げ

H.C. Wainwright lowers Cartesian Therapeutics stock price target to $30 from $40

Cartesian: Maintaining Buy Rating For Expansion Of Descartes-08 For Myositis (NASDAQ:RNAC)